Table 1 Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) areas of inquiry of the SAFER protocol pilot trial
Reach | Effectiveness | Adoption | Implementation | Maintenance |
|---|---|---|---|---|
How many participants were willing to participate in the study? How many people declined participation in the study? Data sources: consent to contact forms and qualitative interviews with service providers | Primary objective: What is the incremental increase in the completion of comprehensive screening and glycemic monitoring? Data sources: chart review, participant clinical record | What challenges did facilities face in the process of implementing the intervention? Data sources: qualitative interviews with service providers | Was the intervention delivered consistently? Data sources: field notes | What were the barriers to continuing this program after completion of the pilot trial, as described by service providers? Data sources: qualitative interviews with service providers |
Of those who agreed to participate, how many attended both the baseline and the follow-up sessions? Data sources: participant clinical record | How many participants with complications, detected as a result of the screening intervention, were referred to a specialist for follow-up care? Data sources: participant clinical record and field notes | According to both participants and providers, was the intervention well received? Data sources: qualitative interviews with service providers and participants | Was it feasible to deliver the intervention in the allotted time frame? Data sources: field notes | According to the participants, would they continue attending the screening intervention on a yearly basis if it became a permanent program? Data sources: qualitative interviews with participants |
What were the clinical and sociodemographic characteristics of the participants? Data sources: baseline questionnaire and participant clinical record | How many participants attended specialist referral appointments? Data sources: participant clinical record and field notes | Â | Was the intervention delivered as intended? Data sources: field notes | Did partnering facilities continue to deliver the intervention after the pilot trial was complete? Why or why not? Data sources: qualitative interviews with service providers |
What was the incremental increase in specialist visits for participants requiring follow-up care? Data sources: chart review, participant clinical record | Â | How many participants attended both visits with the CRN? Data sources: Participant clinical record | What proportion of service providers indicated a willingness to deliver the intervention after the conclusion of the pilot trial? What were their motivations for wanting to do that? Data sources: qualitative interviews with service providers | |
What were the participants’ experiences with the program? Data sources: qualitative interviews with participants |  |  |  |